SABBY MANAGEMENT LLC 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-01-10 2:47 pm Sale |
2022-12-31 | 13G | Context Therapeutics Inc. CNTX |
SABBY MANAGEMENT LLC | 796,706 11.000% |
-434,124![]() (-35.27%) |
Filing |
2022-01-04 9:13 pm Purchase |
2021-12-31 | 13G | Context Therapeutics Inc. CNTX |
SABBY MANAGEMENT LLC | 1,230,830 11.000% |
230,830![]() (+23.08%) |
Filing |
2021-12-06 5:11 pm Purchase |
2021-12-02 | 13G | Context Therapeutics Inc. CNTX |
SABBY MANAGEMENT LLC | 1,000,000 11.000% |
1,000,000![]() (New Position) |
Filing |